<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1054151198438221&amp;ev=PageView&amp;noscript=1">

It looks like your browser is incompatible with our website.

If you are currently using IE 11 or earlier, we recommend you update to the new Microsoft Edge or visit our site on another supported browser.


Press Releases


Reprints Desk To Focus on Software-as-a-Service (SaaS) Offerings in 2017

June 16, 2016

ENCINO, CALIF., June 16, 2016 — Reprints Desk's parent company Research Solutions, Inc. (OTCQB: RSSS), a pioneer in providing on-demand access to scientific, technical and medical (STM) information, today announced plans to focus on software-as-a-service (SaaS) offerings in 2017 that will deliver a best-in-class research platform for businesses and business professionals. The company’s legacy transactional research retrieval services will be one of many integrated product features and service offerings within the new platform. Existing corporate and academic customers will be able to continue using transactional research retrieval services in their preferred research discovery environment.

“Research Solutions’ new SaaS offerings represents a natural evolution for the company, enabling us to expand into multiple new and lucrative market segments,” said Peter Derycz, President and Chief Executive Officer at Research Solutions.  “We are confident that our existing blue chip customer base will benefit from the new SaaS offerings, and also help us to shape it into a blockbuster research intelligence platform.”

Research Solutions currently serves greater than 70 percent of the world's top 25 pharma companies and several Fortune 500 companies, including two of the Fortune 10. The company plans to launch a BETA version of the new SaaS solution in the first calendar quarter of 2017. 

For more information about Research Solutions, visit www.researchsolutions.com.

About Research Solutions
Operating through its wholly owned subsidiary, Reprints Desk®, Inc., Research Solutions, Inc. (OTCQB: RSSS) is a pioneer in providing on-demand access to scientific, technical, and medical (STM) information for life science companies, academic institutions and other research intensive organizations. More than 70 percent of the top 25 pharmaceutical companies in the world rely on services powered by Research Solutions. Article Galaxy™, the company’s cloud-based software solution, gives customers access to the over one million newly published articles each year in addition to tens of millions of articles previously published, helping them to create and speed discoveries, save time and money, and remain copyright-compliant.  Research Solutions has arrangements with numerous STM content publishers that allow electronic access and distribution of their content. In addition to serving end users of content, the company also serves STM publishers by facilitating compliance with applicable copyright laws. For more information about Research Solutions, visit www.researchsolutions.com.

Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements.  Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q.  Examples of forward-looking statements in this press release include statements regarding the features and functionality of the Company’s expanded research platform, the Company’s expansion into new and lucrative markets and the proposed launch of the expanded research platform.  The Company assumes no obligation to update the cautionary information in this release.

Source: Research Solutions

Ready to See
Article Galaxy in Action?

Schedule a call with one of our advisors. We will get you
started with a FREE 14-day trial, with no obligation.